Analyst Ratings for Eliem Therapeutics Inc. (ELYM)

ELYM Rating Summary

  |   Expand Research on ELYM
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 5 / 10   Percentile Rank: 52%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
2/10/2023 H.C. Wainwright N/A Downgrade Neutral
(Buy)		 N/A
(N/A)		 3.34
(5.11)		 52.99% Details
4/25/2022 Guggenheim Yatin Suneja Downgrade Neutral
(Buy)		 N/A
(N/A)		 6.51
(5.11)		 -21.51% Details